Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-24, Stock:LLY, The news for the past five days is as follows:
2018-04-17: NEWS1: Merck's Keytruda Betters Survival in Lung Cancer Combo Study.NEWS2: Merck's Keytruda Betters Survival in Lung Cancer Combo Study.NEWS3: Novartis’s Innovative Medicines Segment in 1Q18.NEWS4: Celldex's Phase II Breast Cancer Study Fails, Shares Plunge.NEWS5: Celldex's Phase II Breast Cancer Study Fails, Shares Plunge.NEWS6: 5 Drug Stocks Poised to Surpass on Earnings This Quarter.NEWS7: Celldex&apos;s Phase II Breast Cancer Study Fails, Shares Plunge.NEWS8: Expectations from Novartis’s 1Q18 Earnings.NEWS9: Risankizumab Could Be AbbVie’s Long-Term Growth Driver.
2018-04-18: NEWS1: Amgen's Aimovig Reduces Episodic Migraine in 30% Patients.NEWS2: Amgen's Aimovig Reduces Episodic Migraine in 30% Patients.NEWS3: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS4: 5 Drug Stocks Poised to Surpass on Earnings This Quarter.NEWS5: 5 Drug Stocks Poised to Surpass on Earnings This Quarter.
2018-04-19: NEWS1: Eli Lilly's Blockbuster Resurrection Story Has Holes.NEWS2: Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug.NEWS3: Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug.NEWS4: FDA staff cites safety issues for Lilly, Incyte's rheumatoid arthritis drug.NEWS5: ANIP, CMD Get FDA Nod, BMY Seeks New Use For Opdivo, Eloxx On Watch.NEWS6: ANIP, CMD Get FDA Nod, BMY Seeks New Use For Opdivo, Eloxx On Watch.
2018-04-20: NEWS1: An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDRâ€¦).NEWS2: An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDRâ€¦).NEWS3: Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer.NEWS4: EARNINGS: Wall Street set the bar high, and beats are coming in stronger than the prior quarter.NEWS5: Top Ranked Growth Stocks to Buy for April 20th.NEWS6: Top Ranked Growth Stocks to Buy for April 20th.NEWS7: Lilly (LLY) to Report Q1 Earnings: What's in the Cards?.NEWS8: Lilly (LLY) to Report Q1 Earnings: What's in the Cards?.NEWS9: Lilly (LLY) to Report Q1 Earnings: What&apos;s in the Cards?.NEWS10: Better Buy: GlaxoSmithKline plc (GSK) vs. Eli Lilly (LLY).NEWS11: Better Buy: GlaxoSmithKline plc (GSK) vs. Eli Lilly (LLY).NEWS12: Lilly to Present Phase 3 Data at AAN 2018 Reinforcing Commitment to New, Innovative Therapies in Migraine.NEWS13: Top Ranked Growth Stocks to Buy for April 20th.NEWS14: Better Buy: GlaxoSmithKline plc (GSK) vs. Eli Lilly (LLY).NEWS15: 3 Biotech Stocks With Major Catalysts Incoming.NEWS16: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS17: See what the IHS Markit Score report has to say about Eli Lilly And Co..
2018-04-23: NEWS1: FDA panel against higher dose of Lilly-Incyte arthritis drug.NEWS2: FDA Panel Backs Lower Dose Of Lilly-Incyte Arthritis Drug, But Not Higher Dose.NEWS3: FDA Panel Backs Lower Dose Of Lilly-Incyte Arthritis Drug, But Not Higher Dose.NEWS4: Pre-Market Earnings Report for April 24, 2018 :  VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX.NEWS5: Pre-Market Earnings Report for April 24, 2018 :  VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX.NEWS6: Analysts’ Recommendations for Eli Lilly & Co. on April 20.NEWS7: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS8: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS9: Eli Lilly’s 1Q18 Estimates: Revenue Growth Expected.NEWS10: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS11: Upcoming Earnings: CAT, LLY And BA Report This Week.NEWS12: Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings.NEWS13: Merck’s Relebactam Met Primary Endpoints in Phase 3 Study.NEWS14: What Analysts Predict for GlaxoSmithKline’s 1Q18 Earnings.NEWS15: Elanco Announces Addition of Chief Financial Officer.

Answer: Decrease